Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy

Amal Alseraihy, Eoin McGrath, Dietger Niederwieser, Christian Chabannon, Jeff Szer, Mohamad Mohty, Mohamed A. Kharfan-Dabaja, Kim Orchard, Joseph Schwartz, Walid Rasheed, Mickey Koh, Nicolaus Kröger, Yoshihisa Kodera, Riad El Fakih, Nina Worel, Lynn Manson, Tuula Rintala, Abdelghani Tabakhi, Bipin Savani, Usama GergisAnna Sureda, Paul W. Eldridge, Ibrahim Yakoub‐Agha, Mehdi Hamadani, Daniel Weisdorf, Hildegard Greinix, Mahmoud Aljurf

Research output: Contribution to journalReview articlepeer-review

Abstract

Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increased demands on healthcare resources. Although improving quality is an integral component of healthcare strategic planning, drivers of quality may be variable, and there is logical debate as to what drives quality in HSCT. Moreover, HSCT programs differ in structure and availability of resources, which drive the type of transplantations provided and determine what is affordable and/or economically feasible. The complexity of HSCT procedures with involvement of different stakeholders necessitates not only regulatory frameworks, but also robust quality systems to ensure consistent standards, demonstrate transparency for regulators, and define what quality means within the HSCT program. In an era of escalating healthcare complexity and heightened fiscal responsibility, transparency and accountability, accreditation contributes to ensuring that care meets the highest standards and can serve as a risk mitigation strategy. Quality management has become an indispensable tool for the management of a complex medical intervention such as HSCT. It allows the transplantation team to monitor its activities and identify areas for continuous improvement. The Worldwide Network for Blood and Marrow Transplantation invited a group of international experts in HSCT and quality management to work on providing a summary document about the key elements in quality and accreditation in HSCT and highlight the foremost challenges of implementing them, with a special focus on low- and middle-income economies.

Original languageEnglish (US)
Pages (from-to)455-462
Number of pages8
JournalTransplantation and Cellular Therapy
Volume28
Issue number8
DOIs
StatePublished - Aug 2022

Bibliographical note

Funding Information:
Financial disclosure: There are no financial conflicts of interest to disclose. Financial disclosure: See Acknowledgments on page XXX.

Publisher Copyright:
© 2022

Keywords

  • Accreditation
  • Hematopoietic stem cell transplantation
  • Quality management

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy'. Together they form a unique fingerprint.

Cite this